Effects of Upgrading From Right Ventricular Pacing to Cardiac Resynchronization Therapy and Comparison With Dual-Chamber Defibrillator
NCT ID: NCT07077928
Last Updated: 2025-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
307 participants
OBSERVATIONAL
2019-01-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
BiventRicular Pacing in prolongEd Atrio-Ventricular intervaL: the REAL-CRT Study
NCT02150538
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
NCT07069738
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
NCT06324682
Ventricular Pace Suppression Study
NCT01053832
Application of Right Atrial Left Ventricular Fusion Pacing in Patients With CRT Indications
NCT03071978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pacemaker upgrade
CRT upgrade
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sinus rhythm,
* age higher than 18,
* EF lower than 35%,
* New York Heart Association (NYHA) class II-IV,
* QRS \>130 ms,
* patients with atrial fibrillation (AF) who converted to sinus rhythm and who remained symptomatic despite 3-6 months of guideline-directed medical therapy.
CRT upgrade group:
* Sinus rhythm,
* age higher than 18,
* EF lower than 35%,
* NYHA class II-IV,
* QRS duration \>130 ms with RV pacing,
-\> 20% RV pacing rate,
* patients with AF who converted to sinus rhythm, at least 6 months since pacemaker implantation, and symptomatic despite 3-6 months of guideline directed medical therapy.
DDDR ICD group:
* Sinus rhythm,
* age higher than 18,
* EF lower than 35%,
* QRS ≤120 ms,
* NYHA class II-IV,
* patients with AF converted to sinus rhythm,
* receiving guideline-directed medical therapy.
Exclusion Criteria
* LV EF higher than 50 %
* NYHA Class 1
* Patients with active infection or cancer
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bursa Postgraduate Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hasan ARI
Professor Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bursa Yüksek İhtisas Hastanesi
Bursa, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Bursa PH CRT Upgrade
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.